Mark J. Krantz

2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteins

Yuan Chuan Lee, Christopher P. Stowell, Mark J. Krantz · Biochemistry · 1976 · 333 citations

Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2

Babita Agrawal, Mark J. Krantz, Mark A. Reddish et al. · Nature Medicine · 1998 · 300 citations

Tumor Biology, Cancer Immunosurveillance, Medicine +6

Attachment of thioglycosides to proteins: enhancement of liver membrane binding

Mark J. Krantz, Neil A. Holtzman, Christopher P. Stowell et al. · Biochemistry · 1976 · 164 citations

Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation.

Babita Agrawal, Mark J. Krantz, Joanne L. Parker et al. · PubMed · 1998 · 153 citations

Muc1 Mucin, T-regulatory Cell, Immune Regulation +16

Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II‐defined cohort of patients with progressive multiple sclerosis: results of a 24‐month double‐blind placebo‐controlled clinical trial and 5 years of follow‐up treatment

Kenneth G. Warren, Ingrid Catz, L. Z. Ferenczi et al. · European Journal of Neurology · 2006 · 145 citations

Translational Medicine, Autoimmune Disease, Disease Progression +15